3.02
-0.3(-9.04%)
Currency In USD
| Previous Close | 3.32 |
| Open | 3.26 |
| Day High | 3.59 |
| Day Low | 2.87 |
| 52-Week High | 100.8 |
| 52-Week Low | 2.77 |
| Volume | 43,572 |
| Average Volume | 1.86M |
| Market Cap | 6.5M |
| PE | -0.18 |
| EPS | -16.41 |
| Moving Average 50 Days | 4.09 |
| Moving Average 200 Days | 7.53 |
| Change | -0.3 |
If you invested $1000 in HCW Biologics Inc. (HCWB) since IPO date, it would be worth $479.37 as of November 09, 2025 at a share price of $3.02. Whereas If you bought $1000 worth of HCW Biologics Inc. (HCWB) shares 3 years ago, it would be worth $32.54 as of November 09, 2025 at a share price of $3.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
GlobeNewswire Inc.
Nov 07, 2025 12:00 PM GMT
Tetra-valent T-cell engager designed to address shortfalls of bi-specific T-cell engagers (BiTE) related to manufacturability, safety profile, and ability to treat a wide spectrum of solid tumorsMIRAMAR, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- HCW
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
GlobeNewswire Inc.
Oct 22, 2025 1:00 PM GMT
Watch the "What This Means" video here Featuring the Company’s pembrolizumab-based immune checkpoint inhibitor MIRAMAR, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based cli
HCW Biologics to Participate in the 2025 Maxim Growth Summit
GlobeNewswire Inc.
Oct 16, 2025 1:25 PM GMT
MIRAMAR, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by targe